The Harvard Medical School is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The Harvard Medical School designates this enduring material for a maximum of 85 AMA PRA Category 1 Credits.
Physicians should claim only the credit commensurate with the extent of their participation in the activity. This activity meets the criteria of the Massachusetts Board of Registration in Medicine for 2.75 credits of Risk Management Study. This includes .75 Credits of Opioid Education and Pain Management Training and .75 Credits of End-of-Life Care Studies. Please check your individual state licensing board requirements before claiming these credits.
Harvard Medical School has long held the standard that its continuing medical education courses be free of commercial bias. In accord with the disclosure policy of the Medical School as well as standards set forth by the Accreditation Council for Continuing Medical Education, course planners, speakers, and content reviewers have been asked to disclose any relevant relationship they, or their spouse or partner, have to companies producing, marketing, re-selling or distributing health care goods or services consumed by, or used on, patients.
In addition, faculty have been asked to list any off-label uses of pharmaceuticals and/or devices for investigational or non-FDA approved purposes that they plan to discuss. Such disclosure is not intended to suggest or condone bias in any presentation